These authors contributed equally.
Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice
Article first published online: 28 FEB 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 4, pages 1555–1563, April 2014
How to Cite
Conrad, E., Resch, T. K., Gogesch, P., Kalinke, U., Bechmann, I., Bogdan, C. and Waibler, Z. (2014), Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice. Hepatology, 59: 1555–1563. doi: 10.1002/hep.26915
Potential conflict of interest: Nothing to report.
This work was supported by the Deutsche Forschungsgemeinschaft (WA 2873/1-1; to Z.W.). C.B. acknowledges grant support by the DFG (SFB 643 project A6) and the Interdisciplinary Center of Clinical Research at the University Hospital Erlangen (IZKF, project A49).
- Issue published online: 24 MAR 2014
- Article first published online: 28 FEB 2014
- Accepted manuscript online: 29 OCT 2013 05:30AM EST
- Manuscript Accepted: 25 OCT 2013
- Manuscript Received: 28 JUN 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.